Zea A, Stewart T, Ascani J, Tate D, Finkel Jimenez B, Wilk A, et al. Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?. PLoS ONE. 2016;11:e0157907 pubmed publisher

Ehrentraut S, Schneider B, Nagel S, Pommerenke C, Quentmeier H, Geffers R, et al. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma. Oncotarget. 2016;7:34201-16 pubmed publisher

Davoodi Semiromi A, Wasserfall C, Xia C, Cooper Dehoff R, Wabitsch M, Clare Salzler M, et al. The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice. PLoS ONE. 2012;7:e36079 pubmed publisher

Uluer E, Aydemir I, Inan S, Ozbilgin K, Vatansever H. Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathway. Acta Histochem. 2012;114:641-6 pubmed publisher

Bixler G, VanGuilder H, Brucklacher R, Kimball S, Bronson S, Freeman W. Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. BMC Med Genomics. 2011;4:40 pubmed publisher